Nations Financial Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.73M Buy
15,663
+221
+1% +$21.3K 0.09% 240
2026
Q2
$1.21M Buy
15,442
+265
+2% +$18.1K 0.06% 335
2026
Q1
$981K Buy
15,177
+183
+1% +$12.9K 0.05% 368
2025
Q4
$1.01M Sell
14,994
-166
-1% -$11.2K 0.05% 353
2025
Q3
$1.11M Buy
15,160
+74
+0.5% +$4.92K 0.07% 295
2025
Q2
$785K Buy
15,086
+657
+5% +$37.4K 0.05% 345
2025
Q1
$921K Buy
14,429
+367
+3% +$21.3K 0.07% 290
2024
Q4
$672K Buy
14,062
+328
+2% +$16.8K 0.05% 369
2024
Q3
$786K Buy
13,734
+815
+6% +$46.7K 0.06% 324
2024
Q2
$676K Buy
12,919
+3,480
+37% +$153K 0.06% 336
2024
Q1
$384K Buy
9,439
+3,067
+48% +$115K 0.03% 486
2023
Q4
$236K Buy
+6,372
New +$240K 0.02% 564

Other funds holding HALO

Nations Financial Group's HALO Position: Q3 2026 in Review

Nations Financial Group increased its Halozyme (HALO) stake by 1.4% in Q3 2026, buying an estimated $21.3K and bringing the position to 15,663 shares worth $1.73M. The position accounts for 0.09% of the portfolio, ranked #240.

Nations Financial Group first reported a position in HALO in Q4 2023 and has held it in 12 quarters since. 636 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Nations Financial Group held 15,663 shares of Halozyme worth $1.73M as of Q3 2026.
  • Nations Financial Group bought 221 Halozyme shares in Q3 2026, an estimated $21.3K.
  • Halozyme made up 0.09% of Nations Financial Group's portfolio in Q3 2026, its #240 holding.
  • Nations Financial Group first reported a position in Halozyme in Q4 2023 and has held it in 12 quarters since.
  • 636 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Nations Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.